.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Julphar
UBS
Mallinckrodt
Novartis
Harvard Business School
AstraZeneca
Express Scripts
Baxter
Chubb

Generated: June 28, 2017

DrugPatentWatch Database Preview

Erythromycin ethylsuccinate; sulfisoxazole acetyl - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin ethylsuccinate; sulfisoxazole acetyl and what is the scope of erythromycin ethylsuccinate; sulfisoxazole acetyl patent protection?

Erythromycin ethylsuccinate; sulfisoxazole acetyl
is the generic ingredient in three branded drugs marketed by Ross Labs, Alra, and Barr, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ninety-eight drug master file entries for erythromycin ethylsuccinate; sulfisoxazole acetyl. Two suppliers are listed for this compound.

Summary for Generic Name: erythromycin ethylsuccinate; sulfisoxazole acetyl

Tradenames:3
Patents:1
Applicants:3
NDAs:3
Drug Master File Entries: see list98
Suppliers / Packagers: see list2
Clinical Trials: see list293
Drug Prices:see low prices
DailyMed Link:erythromycin ethylsuccinate; sulfisoxazole acetyl at DailyMed

Pharmacology for Ingredient: erythromycin ethylsuccinate; sulfisoxazole acetyl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr
ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL062759-001May 20, 1988RXNoYes► Subscribe► Subscribe
Alra
ERYZOLE
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL062758-001Jun 15, 1988DISCNNoNo► Subscribe► Subscribe
Ross Labs
PEDIAZOLE
erythromycin ethylsuccinate; sulfisoxazole acetyl
GRANULE;ORAL050529-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
McKesson
Queensland Health
Merck
Express Scripts
Novartis
Fish and Richardson
Mallinckrodt
Baxter
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot